Rekonnect has raised SEK 4.6 million in a successful pre-seed round where Curus is the largest investor. This represents an important milestone and puts the company in a good position to execute on its ambitious plan to revolutionize the market for post-market surveillance of medical devices. Rekonnect was founded by an experienced group of business and technology experts with a vision to create a breakthrough solution for the fast-growing medical device and healthcare industry. Rekonnect builds on the critical need for medical device manufacturers to track regulatory compliance while offering an important solution to evaluate the impact of medical devices after market introduction. By optimizing workflows and processes that improve the overall performance of medical devices, Rekonnect brings together the key players in the MedTech world by creating a secure, centralized digital ecosystem. – We found that selling medical devices through global distributors created a gap between retailers and users that left users of the products isolated from important support, including customer data and insights into the usability of the products owned by the distributors. With Rekonnect, we seek to digitally transform and centralize device data and user insights and ensure companies comply with MDR regulations,” said Will Gray, co-founder and CEO. Rekonnect enables healthcare professionals, retailers, distributors and medical device manufacturers to effortlessly exchange valuable data, fostering a collaborative environment that drives innovation and improves patient outcomes. Investors in this pre-seed round consisted of Curus, LOOP Capital, Fast Track Capital and Angcell Ventures, along with several well-known angel investors such as Ingela Hallberg, Emil Sjödin and Björn Andersson. The new share issue will be used to further develop the platform, acquire customers and expand the core team. – Will and his team have developed a great platform that clearly solves a market problem and can easily scale internationally. We are excited to be part of the expanded Rekonnect team as an investor and help the team in the best way to build a leading global platform for post-market surveillance of medical devices, says Erik Olsson Nyrén, Investment Manager at Curus.

For more information: Erik Olsson Nyrén, Investment Manager Curus [email protected],+46 708 37 73 54 Will Gray, Co-Founder and CEO Rekonnect [email protected],+46 700 37 21 93  About Rekonnect Rekonnect is a B2B SaaS solution designed for medical device companies to achieve post-market success. Rekonnect offers advanced stakeholder relationship management, device information management, service management and more. For more information, please visit Rekonnect.About Curus Curus is a Nordic-based investment company focused on healthcare investments. To date, Curus has made around 25 investments, both minority and majority investments, supporting exceptional entrepreneurs. Our mission is to support the best entrepreneurs with our network, knowledge, marketing, strategic advice and capital to create long-term value. For more information, visit Curus.